Chembio Diagnostics has applied to the FDA for approval of the DPP SARS-CoV-2 Antigen testing system. The system analyzes a minimally invasive nasal swab using DPP Micro Reader or DPP Micro Reader 2 optical analyzers, which can detect COVID-19 in 20 minutes.